Revisión de los niños diagnosticados de esferocitosis hereditaria (EH) antes de los 2 Se objetivó anemia en el % de los pacientes e ictericia en el 44%. Download Citation on ResearchGate | Esferocitosis hereditaria: Aspectos clínicos , characterized by hemolytic anemia of variable severity, with spherocytes in. Esferocitosis Hereditaria Anemia Esferocitosis Hereditaria 1) Defecto de la membrana del eritrocito. 2) Retención selectiva por el bazo normal.
|Published (Last):||8 May 2017|
|PDF File Size:||7.30 Mb|
|ePub File Size:||15.92 Mb|
|Price:||Free* [*Free Regsitration Required]|
Clinico-hematological profile of hereditary spherocytosis: Referencias -Mayelin Herrera Garcia. Splenectomy for hereditary spherocytosis: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. Blood Anfmia Mol Dis ; The Italian survey on hereditary spherocytosis.
The prognosis is variable and depends on the severity of the disease and any associated complications. Splenectomy usually results in disappearance of anemia and clear amelioration of hemolytic markers.
Molecular genetic testing is not routinely used to confirm diagnosis. Specialised Social Services Eurordis directory.
Esferocitosis hereditaria by Jazmin Cózar Madero on Prezi
The documents contained in this web site are presented for information purposes only. J Thromb Thrombolysis ;17 3: Genetic counseling is recommended in families with a history of HS. Journal of Medical Cases. J Lab Clin Med. Other search option s Alphabetical list. A combined splenectomy heredtaria cholecystectomy may be beneficial in patients with gallstones.
Etiology HS is caused by mutations in one of the following genes: Erythroid membrane protein defects in hereditary spherocytosis. Rare complications include poor growth, skin ulceration, chronic dermatitis, high output heart failure, and secondary iron overload. Oxygen affinity and compensated hemolysis in hereditary spherocytosis. Only comments written in English can be processed.
Pre and hegeditaria vaccine prophylaxis and prophylactic antibiotics are recommended in order to prevent infections. Guidelines for the diagnosis and management of hereditary spherocytosis update. Hereditary Spherocytosis in Neonates with Hyperbilirubinemia.
There was a problem providing the content you requested
Treatment involves management of jaundice phototherapy and even exchange blood transfusion to prevent hyperbilirubinemic encephalopathy and RBC transfusions in case of severe, symptomatic anemia. Prognosis The prognosis is variable and depends on the severity of the disease and any associated complications.
Antenatal diagnosis Prenatal diagnosis for at-risk pregnancies is possible if disease-causing mutations have been identified in a family, but it is not routinely performed due to the usually mild disease course. Int J Pediatr Hematol Oncol ; 2: Prenatal diagnosis for at-risk pregnancies is possible if disease-causing mutations have been identified in a family, but it is not routinely performed due to the usually mild disease course.
It is not indicated in patients with HS trait, whereas it is usually necessary in severe cases, albeit delayed if possible until the age of 6 years.
Summary and related texts. HS is caused by mutations in one of the following genes: King on behalf of the General Haematology Task Force of the British Committee for Standards in Haematology Guidelines for the diagnosis and management of hereditary spherocytosis.
For all other comments, please send your remarks via contact us. Hereditary spherocytosis is a congenital hemolytic anemia with a wide clinical spectrum from symptom-free carriers to severe hemolysis characterized by anemia, variable jaundice, splenomegaly and cholelithiasis.
The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.
Autosomal recessive inheritance and de novo mutations have also been reported, but are less common.